Ipsen Biopharm Limited
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$140Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
22clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Alberto Esquenazi | Philadelphia, PA | Physical Medicine & Rehabilitation | $23,216.53 |
| Atul Patel | Overland Park, KS | Physical Medicine & Rehabilitation | $21,286.00 |
| Monica Verduzco-Gutierrez | San Antonio, TX | Brain Injury Medicine (Physical Medicine & Rehabilitation) | $18,255.00 |
| Mark Nestor | Aventura, FL | Dermatology | $16,852.50 |
| Anthony Benedetto | Philadelphia, PA | Dermatology | $15,200.00 |
| Toni Choueiri | Boston, MA | Medical Oncology | $8,330.00 |
| Maria Fleseriu | Portland, OR | Endocrinology, Diabetes & Metabolism | $4,625.00 |
| Ziyad Ayyoub | Paramount, CA | Physical Medicine & Rehabilitation | $4,380.00 |
| Richard Zorowitz | Washington, DC | Physical Medicine & Rehabilitation | $4,260.00 |
| Richard Trosch | Farmington Hills, MI | Neurology (Psychiatry & Neurology) | $3,520.00 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.